Try it
Pharmacology · CNS drugs and antiepileptics: ziconotide
Sample itemA patient with refractory cancer pain receives an intrathecal infusion of a peptide derived from the venom of a marine cone snail. Which channel does it block?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. N-type voltage-gated calcium channel
Ziconotide is a synthetic form of omega-conotoxin that blocks N-type calcium channels on nociceptive afferents in the dorsal horn. It is given intrathecally for severe refractory pain, and psychiatric and neurological adverse effects limit its use. It is not an opioid, so there is no respiratory depression or tolerance.
Option by option
A. NMDA receptor channel
NMDA channel block is the action of ketamine.
B. Mu opioid receptor-coupled potassium channel
Opioid receptor activation is the action of intrathecal morphine, not of ziconotide.
C. N-type voltage-gated calcium channel (correct)
Correct. Ziconotide blocks N-type calcium channels in the spinal cord.
D. Voltage-gated sodium channel Nav1.7
Sodium channel block is the action of local anaesthetics.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?